Michael Pulley

4.0k total citations
17 papers, 319 citations indexed

About

Michael Pulley is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, Michael Pulley has authored 17 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Michael Pulley's work include Myasthenia Gravis and Thymoma (8 papers), Peripheral Neuropathies and Disorders (6 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Michael Pulley is often cited by papers focused on Myasthenia Gravis and Thymoma (8 papers), Peripheral Neuropathies and Disorders (6 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Michael Pulley collaborates with scholars based in United States, Switzerland and Brazil. Michael Pulley's co-authors include Janette M. Krum, Jeffrey M. Rosenstein, Nancy H. Sternberger, Ludwig A. Sternberger, Richard J. Nowak, Diantha B. Howard, Melissa Fellman, Michael K. Hehir, Ted M. Burns and James F. Howard and has published in prestigious journals such as Neurology, The Lancet Neurology and Journal of the Neurological Sciences.

In The Last Decade

Michael Pulley

14 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Pulley United States	6	229	73	46	28	28	17	319
Vittorio Mantero Italy	11	183 0.8×	58 0.8×	31 0.7×	39 1.4×	18 0.6×	32	288
Vitalie Lisnic Moldova	8	233 1.0×	37 0.5×	88 1.9×	22 0.8×	14 0.5×	21	339
Ahmed Elsotouhy Qatar	10	107 0.5×	39 0.5×	27 0.6×	14 0.5×	21 0.8×	23	237
Aniello Iovino Italy	10	141 0.6×	48 0.7×	38 0.8×	76 2.7×	94 3.4×	27	302
Victor Hugo Rocha Marussi Brazil	8	85 0.4×	24 0.3×	32 0.7×	45 1.6×	50 1.8×	26	218
Seok‐Jin Choi South Korea	8	115 0.5×	10 0.1×	30 0.7×	36 1.3×	27 1.0×	35	237
Weihong Lin China	10	130 0.6×	22 0.3×	13 0.3×	29 1.0×	17 0.6×	30	285
Mustafa Al-Chalabi United States	8	101 0.4×	60 0.8×	14 0.3×	48 1.7×	21 0.8×	23	293
Julien Hébert United States	8	211 0.9×	30 0.4×	11 0.2×	39 1.4×	22 0.8×	31	283
Marta Lipowska Poland	10	145 0.6×	26 0.4×	13 0.3×	56 2.0×	67 2.4×	24	248

Countries citing papers authored by Michael Pulley

Since Specialization

Citations

This map shows the geographic impact of Michael Pulley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pulley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pulley more than expected).

Fields of papers citing papers by Michael Pulley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pulley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pulley. The network helps show where Michael Pulley may publish in the future.

Co-authorship network of co-authors of Michael Pulley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pulley. A scholar is included among the top collaborators of Michael Pulley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pulley. Michael Pulley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Howard, James F., et al.. (2025). First analysis of the Myasthenia Gravis SPOTLIGHT Registry: outcomes with eculizumab and ravulizumab. Journal of the Neurological Sciences. 476. 123628–123628.

Habib, Ali A., Chongbo Zhao, Inmaculada Aban, et al.. (2025). Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. The Lancet Neurology. 24(2). 117–127. 10 indexed citations

Narayanaswami, Pushpa, Michael Pulley, James Winkley, et al.. (2025). Effectiveness and Safety of Ravulizumab in Generalized Myasthenia Gravis (gMG): Updated Analysis from a Global Registry (P1-11.014). Neurology. 104(7_Supplement_1).

Yee, Karen, et al.. (2025). Outcomes for Patients with Generalized Myasthenia Gravis Prescribed Ravulizumab or Efgartigimod Treatment: A Retrospective Medical Record Analysis (P1-11.001). Neurology. 104(7_Supplement_1).

Habib, Ali A., Chongbo Zhao, Inmaculada Aban, et al.. (2024). LUMINESCE, a Phase 3 Study of Satralizumab in Generalized Myasthenia Gravis (gMG): Baseline Characteristics (P10-11.015). Neurology. 102(7_supplement_1). 1 indexed citations

Pulley, Michael, et al.. (2023). Change in Concomitant Therapies for Generalized Myasthenia Gravis in Patients Receiving Eculizumab: a Retrospective Analysis of Registry Data (P1-5.002). Neurology. 100(17_supplement_2). 4 indexed citations

Pulley, Michael, et al.. (2023). Change in concomitant therapies for generalized myasthenia gravis in patients receiving eculizumab: A retrospective analysis of registry data. Journal of the Neurological Sciences. 455. 121092–121092. 1 indexed citations

Miller, Sally K., et al.. (2022). Clinical Challenges of Acute Porphyria in the Young Adult. The Neurohospitalist. 12(2). 377–382. 1 indexed citations

Kushlaf, Hani, Zoya Zaeem, Zaeem A. Siddiqi, et al.. (2022). Patient preference for virtual versus in‐person visits in neuromuscular clinical practice. Muscle & Nerve. 66(2). 142–147. 5 indexed citations

10.

Beydoun, Said R., et al.. (2021). Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg. Frontiers in Neurology. 12. 638816–638816. 10 indexed citations

11.

Govindarajan, Raghav, James D. Berry, Sabrina Paganoni, Michael Pulley, & Zachary Simmons. (2020). Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle & Nerve. 62(3). 321–326. 19 indexed citations

12.

Pulley, Michael, et al.. (2018). Multidisciplinary amyotrophic lateral sclerosis telemedicine care: The store and forward method. Muscle & Nerve. 59(1). 34–39. 25 indexed citations

13.

Hehir, Michael K., Lisa D. Hobson‐Webb, Michael Benatar, et al.. (2017). Rituximab as treatment for anti-MuSK myasthenia gravis. Neurology. 89(10). 1069–1077. 166 indexed citations

14.

Pulley, Michael, et al.. (2015). Feasibility study of the use of telemedicine in the care of ALS patients. (P4.127). Neurology. 84(14_supplement). 2 indexed citations

15.

Pulley, Michael, et al.. (2012). Two new gene mutations for late onset mitochondrial neurogastrointestinal encephalopathy (MNGIE). Translational Neuroscience. 3(4). 413–414. 3 indexed citations

16.

Pulley, Michael, et al.. (2007). Hemorrhagic upper extremity complications from tissue plasminogen activator.. PubMed. 16(1). 27–30. 3 indexed citations

17.

Rosenstein, Jeffrey M., Janette M. Krum, Ludwig A. Sternberger, Michael Pulley, & Nancy H. Sternberger. (1992). Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis. Developmental Brain Research. 66(1). 47–54. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact